PIII Historical Financial Ratios
PIII Stock | USD 0.19 0.01 5.00% |
P3 Health is promptly reporting on over 89 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Book Value Per Share of 3.91, Invested Capital of 0.0, Average Payables of 0.0 or Stock Based Compensation To Revenue of 0.0043 will help investors to properly organize and evaluate P3 Health Partners financial condition quickly.
PIII |
About PIII Financial Ratios Analysis
P3 Health PartnersFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate P3 Health investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on PIII financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across P3 Health history.
P3 Health Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing P3 Health Partners stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on P3 Health sales, a figure that is much harder to manipulate than other P3 Health Partners multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Ev To Sales
The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.Payables Turnover
A liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable.Most ratios from P3 Health's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into P3 Health Partners current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in P3 Health Partners. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. As of now, P3 Health's Days Payables Outstanding is decreasing as compared to previous years. The P3 Health's current Income Quality is estimated to increase to 1.24, while PTB Ratio is projected to decrease to 0.96.
2022 | 2023 | 2024 | 2025 (projected) | Graham Number | 4.54 | 4.53 | 4.08 | 3.22 | Receivables Turnover | 13.19 | 10.43 | 9.38 | 8.91 |
P3 Health fundamentals Correlations
Click cells to compare fundamentals
P3 Health Account Relationship Matchups
High Positive Relationship
High Negative Relationship
P3 Health fundamentals Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Price To Sales Ratio | 3.17 | 0.79 | 5.96E-4 | 0.0729 | 0.0982 | 0.11 | |
Ptb Ratio | (13.73) | 1.07 | 13.07 | 0.87 | 1.01 | 0.96 | |
Days Sales Outstanding | 34.31 | 0.0382 | 27.68 | 35.01 | 40.26 | 31.26 | |
Book Value Per Share | (1.16) | 49.64 | 12.57 | 4.57 | 4.11 | 3.91 | |
Free Cash Flow Yield | (0.0719) | (0.24) | (0.001676) | (0.63) | (0.72) | (0.68) | |
Operating Cash Flow Per Share | (0.62) | (1.6) | (0.003031) | (0.8) | (0.92) | (0.97) | |
Stock Based Compensation To Revenue | 9.22E-4 | 1.7E-5 | 0.0185 | 0.004721 | 0.004249 | 0.004334 | |
Capex To Depreciation | 3.68 | 0.39 | 0.0256 | 0.0211 | 0.0242 | 0.023 | |
Pb Ratio | (13.73) | 1.07 | 13.07 | 0.87 | 1.01 | 0.96 | |
Ev To Sales | 0.81 | 4.93E-4 | 0.16 | 0.17 | 0.19 | 0.18 | |
Free Cash Flow Per Share | (0.7) | (1.68) | (0.003085) | (0.82) | (0.94) | (0.99) | |
Roic | (2.77) | (0.004648) | (2.46) | (0.3) | (0.27) | (0.29) | |
Net Income Per Share | (0.79) | (0.24) | (6.5) | (0.61) | (0.7) | (0.74) | |
Days Of Inventory On Hand | 2.74 | (31.4K) | 0.29 | (1.07) | (1.23) | (1.29) | |
Payables Turnover | 50.45 | 122.16 | 99.16 | 142.53 | 128.28 | 77.19 | |
Capex To Revenue | 0.006028 | 7.0E-6 | 2.0E-6 | 0.001443 | 0.001659 | 0.001576 | |
Pocfratio | (15.56) | (4.4) | (607.09) | (1.63) | (1.88) | (1.97) | |
Interest Coverage | (13.86) | (2.9K) | (136.92) | (10.5) | (12.08) | (12.68) | |
Pfcf Ratio | (13.9) | (4.19) | (596.52) | (1.6) | (1.84) | (1.93) | |
Days Payables Outstanding | 7.23 | 2.99 | 3.68 | 2.56 | 2.94 | 4.8 | |
Income Quality | 0.54 | 0.42 | 0.0807 | 1.32 | 1.18 | 1.24 | |
Roe | 1.13 | (0.0369) | (46.14) | (0.41) | (0.47) | (0.49) | |
Ev To Operating Cash Flow | (16.08) | (3.64) | (1.3K) | (2.76) | (3.18) | (3.33) | |
Pe Ratio | (12.18) | (29.04) | (0.28) | (2.15) | (1.94) | (2.03) | |
Return On Tangible Assets | (0.32) | (0.0461) | (2.15) | (0.3) | (0.34) | (0.36) | |
Ev To Free Cash Flow | (14.37) | (3.47) | (1.3K) | (2.7) | (3.1) | (3.26) | |
Earnings Yield | (0.0821) | (0.0344) | (3.53) | (0.46) | (0.53) | (0.56) | |
Intangibles To Total Assets | 0.00872 | 0.91 | 0.86 | 0.77 | 0.7 | 0.41 | |
Net Debt To E B I T D A | (0.46) | 0.27 | (0.0605) | (1.06) | (1.21) | (1.15) | |
Current Ratio | 0.93 | 1.01 | 0.42 | 0.55 | 0.64 | 0.85 | |
Tangible Book Value Per Share | (1.19) | (1.96) | (5.49) | (2.46) | (2.82) | (2.97) | |
Receivables Turnover | 10.64 | 9.6K | 13.19 | 10.43 | 9.38 | 8.91 | |
Graham Number | 3.55 | 5.99 | 4.54 | 4.53 | 4.08 | 3.22 | |
Shareholders Equity Per Share | (0.7) | 6.58 | 0.14 | 1.5 | 1.35 | 1.22 | |
Debt To Equity | (1.76) | 0.33 | 18.1 | 0.86 | 0.77 | 0.73 | |
Capex Per Share | 0.074 | 0.082 | 5.4E-5 | 0.0193 | 0.0221 | 0.021 |
Currently Active Assets on Macroaxis
When determining whether P3 Health Partners is a strong investment it is important to analyze P3 Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact P3 Health's future performance. For an informed investment choice regarding PIII Stock, refer to the following important reports:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in P3 Health Partners. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of P3 Health. If investors know PIII will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about P3 Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.86) | Revenue Per Share | Quarterly Revenue Growth 0.256 | Return On Assets | Return On Equity |
The market value of P3 Health Partners is measured differently than its book value, which is the value of PIII that is recorded on the company's balance sheet. Investors also form their own opinion of P3 Health's value that differs from its market value or its book value, called intrinsic value, which is P3 Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because P3 Health's market value can be influenced by many factors that don't directly affect P3 Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between P3 Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if P3 Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, P3 Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.